CA2503517A1 - Method for diagnosing diffuse-type gastric cancer - Google Patents
Method for diagnosing diffuse-type gastric cancer Download PDFInfo
- Publication number
- CA2503517A1 CA2503517A1 CA002503517A CA2503517A CA2503517A1 CA 2503517 A1 CA2503517 A1 CA 2503517A1 CA 002503517 A CA002503517 A CA 002503517A CA 2503517 A CA2503517 A CA 2503517A CA 2503517 A1 CA2503517 A1 CA 2503517A1
- Authority
- CA
- Canada
- Prior art keywords
- dgc
- expression
- gene
- group
- subject
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- G01N33/5753—
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57446—Specifically defined cancers of stomach or intestine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Cell Biology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US42119302P | 2002-10-25 | 2002-10-25 | |
| US60/421,193 | 2002-10-25 | ||
| PCT/JP2003/011975 WO2004038045A2 (en) | 2002-10-25 | 2003-09-19 | Method for diagnosing diffuse-type gastric cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2503517A1 true CA2503517A1 (en) | 2004-05-06 |
Family
ID=32176680
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002503517A Abandoned CA2503517A1 (en) | 2002-10-25 | 2003-09-19 | Method for diagnosing diffuse-type gastric cancer |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20060204960A1 (enExample) |
| EP (1) | EP1554408A2 (enExample) |
| JP (1) | JP2006503575A (enExample) |
| AU (1) | AU2003263607A1 (enExample) |
| CA (1) | CA2503517A1 (enExample) |
| WO (1) | WO2004038045A2 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103435683B (zh) * | 2006-06-16 | 2016-02-03 | 肿瘤疗法·科学股份有限公司 | 来自sparc的癌排斥抗原肽以及含有该肽的药物 |
| US7811778B2 (en) * | 2006-09-06 | 2010-10-12 | Vanderbilt University | Methods of screening for gastrointestinal cancer |
| WO2009038754A2 (en) * | 2007-09-19 | 2009-03-26 | The Research Foundation Of State University Of New York | Gene expression signatures in enriched tumor cell samples |
| WO2009131365A2 (ko) * | 2008-04-21 | 2009-10-29 | 한국생명공학연구원 | 위암 진단 마커로서의 cst1, dcc1, ifitm1 또는 melk |
| US20100203510A1 (en) * | 2009-02-10 | 2010-08-12 | Industrial Cooperation Foundation Chonbuk National University | Ppia marker for diagnosis of liver cancer and antibody, and screening method of compounds useful for inhibiting liver cancer |
| KR101187317B1 (ko) | 2009-03-06 | 2012-10-02 | 한국과학기술원 | 산재성 위암 감수성 예측용 다형성 마커 및 이를 이용한 산재성 위암 감수성 예측 방법 |
| GB201505585D0 (en) | 2015-03-31 | 2015-05-13 | Immatics Biotechnologies Gmbh | Novel peptides and combination of peptides and scaffolds for use in immunotherapy against renal cell carinoma (RCC) and other cancers |
| KR102427871B1 (ko) * | 2020-02-28 | 2022-08-02 | 아주대학교산학협력단 | 미만형 위암 진단용 바이오마커 조성물 및 이의 의학적 용도 |
| CN111560439B (zh) * | 2020-06-19 | 2022-12-30 | 江苏华美健晟生物科技有限公司 | 检测外周血外泌体circ-LRP8的引物、试剂盒及其在胃癌肝转移中的应用 |
| CN119365612A (zh) * | 2022-06-17 | 2025-01-24 | 韩国生命工学研究院 | 弥漫型胃癌的预后诊断标记物及治疗靶点 |
| CN116516008B (zh) * | 2023-05-04 | 2024-05-07 | 中国中医科学院望京医院(中国中医科学院骨伤科研究所) | 胃粘膜肠上皮化生标志物jun及其应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI971124A0 (fi) * | 1997-03-18 | 1997-03-18 | Locus Genex Oy | Metod foer diagnostisering av magcancer |
| SE9704559L (sv) * | 1997-12-08 | 1999-05-17 | Anders Lutteman | Anordning vid spinnrulle |
| US20030040617A9 (en) * | 1999-03-12 | 2003-02-27 | Rosen Craig A. | Nucleic acids, proteins and antibodies |
| US20020151696A1 (en) * | 2000-11-29 | 2002-10-17 | Millennium Pharmaceuticals, Inc. | 84242,8035, 55304, 52999, and 21999, novel human proteins and methods of use thereof |
| US20020102617A1 (en) * | 2000-08-03 | 2002-08-01 | Macbeath Gavin | Protein microarrays |
| US20020055827A1 (en) * | 2000-10-06 | 2002-05-09 | Chris Kyriakakis | Modeling of head related transfer functions for immersive audio using a state-space approach |
| US20040236091A1 (en) * | 2001-03-28 | 2004-11-25 | Chicz Roman M. | Translational profiling |
| ATE457359T1 (de) * | 2001-04-02 | 2010-02-15 | Univ South Florida | Auf lps-reagierendes chs1/beige-ähnliches anker- gen und therapeutische anwendungen davon |
-
2003
- 2003-09-19 JP JP2004546398A patent/JP2006503575A/ja not_active Withdrawn
- 2003-09-19 WO PCT/JP2003/011975 patent/WO2004038045A2/en not_active Ceased
- 2003-09-19 EP EP03809437A patent/EP1554408A2/en not_active Withdrawn
- 2003-09-19 CA CA002503517A patent/CA2503517A1/en not_active Abandoned
- 2003-09-19 AU AU2003263607A patent/AU2003263607A1/en not_active Abandoned
- 2003-09-19 US US10/533,026 patent/US20060204960A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2004038045A3 (en) | 2005-02-24 |
| US20060204960A1 (en) | 2006-09-14 |
| WO2004038045A2 (en) | 2004-05-06 |
| EP1554408A2 (en) | 2005-07-20 |
| AU2003263607A8 (en) | 2004-05-13 |
| AU2003263607A1 (en) | 2004-05-13 |
| JP2006503575A (ja) | 2006-02-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20070092519A1 (en) | Method for diagnosing chronic myeloid leukemia | |
| US20070054849A1 (en) | Method for diagnosing hepatocellular carcinomas | |
| EP1907581A2 (en) | Method of diagnosing small cell lung cancer | |
| JP2006500948A (ja) | 膵臓癌を診断する方法 | |
| US20060194199A1 (en) | Method for diagnosing testicular seminomas | |
| US8029981B2 (en) | Hypoxia-inducible protein 2 (HIG2), a diagnostic marker for clear cell renal cell carcinoma | |
| US20130084578A1 (en) | Breast cancer related gene znfn3a1 | |
| US20060105333A1 (en) | Method for diagnosis of intestinal-type gastric tumors | |
| KR20050074467A (ko) | 전립선암 진단 방법 | |
| US20060204960A1 (en) | Method for diagnosing diffuse-type gastric cancers | |
| US20080063640A1 (en) | Pin-Prc Transition Genes | |
| CN101273131A (zh) | 胰腺癌相关基因cst6和gabrp | |
| US20080199468A1 (en) | Method For Diagnosing Colorectal Cancers |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Discontinued |